Plant stem cells could be fruitful source of low-cost cancer drug
A popular cancer drug could be produced cheaply and sustainably using stem cells derived from trees, a study suggests. Researchers have isolated and grown stem cells from a yew tree whose bark is a natural source of the anticancer compound paclitaxel. The development could enable the compound to be produced on a commercial scale at low cost, with no harmful by-products.
Scientists and engineers behind the development say the drug treatment – currently used on lung, ovarian, breast, head and neck cancer – could become cheaper and more widely available. The study was carried out by the University of Edinburgh and the Unhwa Biotech company in Korea.
Currently, an extract from yew tree bark is used to industrially manufacture the compound paclitaxel. However, this process is expensive, requires supplies of mature trees, and creates environmentally damaging by-products.
Researchers claim that using stem cells – self-renewing tree cells which can be manipulated to produce large amounts of the active compound – would effectively create an abundant supply of the drug. The process would cost far less than conventional methods.
Scientists behind the project have also cultured stem cells from other plants with medical applications, indicating that the technique could be used to manufacture other important pharmaceuticals besides paclitaxel.
The study was published in Nature Biotechnology and supported by the Biotechnology and Biological Sciences Research Council and the Engineering and Physical Sciences Research Council.
Professor Gary Loake, of the University of Edinburgh's School of Biological Sciences, who led/took part in the study, said: "Plants are a rich source of medicine – around one in four drugs in use today is derived from plants. Our findings could deliver a low-cost, clean and safe way to harness the healing power of plants, potentially helping to treat cancer, and other conditions."
Source: University of Edinburgh
Articles on the same topic
- New test measures DNA methylation levels to predict colon cancerThu, 28 Oct 2010, 18:04:42 UTC
- Researchers build colony of colon cancer stem cells to test new approach to therapyThu, 28 Oct 2010, 17:03:59 UTC
- Too much SP2 protein turns stem cells into 'evil twin' cancer cellsWed, 27 Oct 2010, 19:03:29 UTC
Other sources
- Researchers build colony of colon cancer stem cells to test new approach to therapyfrom Science DailyThu, 28 Oct 2010, 19:31:25 UTC
- New DNA Tests Aimed at Reducing Colon Cancerfrom NY Times ScienceThu, 28 Oct 2010, 18:50:18 UTC
- New DNA Tests Aimed at Reducing Colon Cancerfrom NY Times HealthThu, 28 Oct 2010, 18:50:16 UTC
- New test measures DNA methylation levels to predict colon cancerfrom Science DailyThu, 28 Oct 2010, 18:30:17 UTC
- New test measures DNA methylation levels to predict colon cancerfrom Science BlogThu, 28 Oct 2010, 18:00:53 UTC
- Researchers build colony of colon cancer stem cells to test new approach to therapyfrom PhysorgThu, 28 Oct 2010, 18:00:38 UTC
- New test measures DNA methylation levels to predict colon cancerfrom PhysorgThu, 28 Oct 2010, 18:00:32 UTC
- Too much SP2 protein turns stem cells into 'evil twin' cancer cellsfrom Science DailyThu, 28 Oct 2010, 13:31:37 UTC
- Too much SP2 protein turns stem cells into ‘evil twin’ cancer cellsfrom Science BlogWed, 27 Oct 2010, 19:30:36 UTC
- Too much SP2 protein turns stem cells into 'evil twin' cancer cellsfrom PhysorgWed, 27 Oct 2010, 19:30:30 UTC
- Plant stem cells could be fruitful source of low-cost cancer drugfrom Science DailyTue, 26 Oct 2010, 13:21:07 UTC
- Plant stem cells could be fruitful source of low-cost cancer drugfrom Science BlogMon, 25 Oct 2010, 15:20:53 UTC
- Plant stem cells could be fruitful source of low-cost cancer drugfrom PhysorgMon, 25 Oct 2010, 14:50:43 UTC